文献速递临床免疫临床微生物

COVID-19患者中QuantiFERON-TB Gold Plus不确定结果率升高

Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.
PubMed 文献 · J Clin Microbiol · 2021-08-04

本文评述Ward等在J Clin Microbiol的研究,该研究发现COVID-19患者中QuantiFERON-TB Gold Plus不确定结果率升高,且不依赖免疫抑制剂和淋巴细胞减少。不确定结果患者趋向于生存率下降及血清IL-6和IL-10升高,但差异无统计学意义。提示危重COVID-19患者可能存在Th1受损,临床医生应知晓该现象。

要点

  • COVID-19患者QFT-TB Gold Plus不确定结果率升高。
  • 该升高不依赖免疫抑制剂使用和淋巴细胞减少。
  • 不确定结果患者趋向生存率下降及IL-6、IL-10升高,但无统计学意义。

核心结论

  • 危重COVID-19患者中QuantiFERON-TB Gold Plus不确定结果率升高,临床医生应知晓。

研究设计与样本

  • 本文为对J Clin Microbiol刊载的Ward等研究的评述,原研究具体设计与样本量未在摘要中报告。

主要发现

  • COVID-19患者中QuantiFERON-TB Gold Plus不确定结果率升高,且不依赖免疫抑制剂和淋巴细胞减少。
  • 不确定结果患者趋向生存率下降及血清IL-6和IL-10水平升高,但差异无统计学意义。
  • 该细胞因子表达模式提示危重COVID-19患者Th1功能受损,特别是干扰素γ产生受损。

临床怎么用

  • 临床医生应意识到危重COVID-19患者中QuantiFERON-TB Gold Plus不确定结果率升高。

局限性

  • 摘要未报告原研究的具体样本量、设计细节及统计学数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Interferon gamma release assays are used to screen various patient populations for latent tuberculosis infection. In this issue of the Journal of Clinical Microbiology, J. D. Ward, C. Cornaby, and J. L. Schmitz (J Clin Microbiol 59:e00811-21, 2021, https://doi.org/10.1128/JCM.00811-21) investigated an increased indeterminate rate in the QuantiFERON-TB Gold Plus assay among COVID-19 patients that was independent of immunosuppressive agents and lymphopenia. In their study, COVID-19 patients with indeterminate QuantiFERON-TB Gold Plus results trended toward decreased survival as well as increased serum interleukin-6 (IL-6) and IL-10 levels, although the differences were not statistically significant. They suggest that this pattern of cytokine expression supports an impairment of Th1, specifically interferon gamma production, in critically ill COVID-19 patients, as indicated by indeterminate QuantiFERON-TB Gold Plus results. Clinicians should be aware of the increased rate of indeterminate QuantiFERON-TB Gold Plus results in critically ill COVID-19 patients.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Shier KL. Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients. J Clin Microbiol. 2021. PMID: 34346720. doi:10.1128/JCM.01414-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。